(Adds overseas regulatory reviews in paragraph 9) Nov 18 (Reuters) – The US FDA on Wednesday approved Sanofi's oral drug venglustat, making it the first treatment for a type of rare genetic condition
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Echo Wang Nov 18 (Reuters) - Anthropic priced its initial public offering at $83 a…
By Echo Wang Nov 18 (Reuters) - Anthropic priced its initial public offering at $83 a…
* Judge extends earlier restraining order for another two weeks * Extension gives judge more…
VIDEO SHOWS: ATP FINALS IVAN LENDL GROUP HIGHLIGHTS WITH FRANCES TIAFOE BEATING FLAVIO COBOLLI FOR…
Nov 18 (Reuters) - A US House panel has asked Microsoft to brief lawmakers on…
ADDS CNN INTERVIEW WITH MUNN AND KELLY The Reuters Television Daybook Today and tomorrow -----…